Therapeutic duplication may be a concern for a patient prescribed both trazodone and:

Rationale

Therapeutic duplication may be a concern for a patient prescribed both trazodone and nortriptyline.

Both trazodone and nortriptyline are antidepressant medications that belong to similar classes, which can lead to therapeutic duplication. This overlap may increase the risk of side effects and potentially lead to serotonin syndrome, making careful monitoring essential when these drugs are prescribed together.

A (Nabumetone) YOUR ANSWER

Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) used primarily for pain and inflammation management. It does not share a pharmacological class or therapeutic purpose with trazodone, which is an antidepressant. Therefore, combining these medications does not create a concern for therapeutic duplication.

B (Nystatin) YOUR ANSWER

Nystatin is an antifungal medication used to treat fungal infections. It acts on a completely different biological pathway than trazodone and is not indicated for any mood or psychiatric disorders. Thus, there is no overlap in therapeutic effects, and no concern for therapeutic duplication arises with this combination.

C (Nortriptyline) CORRECT

Nortriptyline is a tricyclic antidepressant that is used to treat depression and can also be prescribed for other conditions such as chronic pain. When taken alongside trazodone, both medications can exert similar effects on serotonin levels and mood, leading to concerns about therapeutic duplication and increased side effects.

D (Nicardipine) YOUR ANSWER

Nicardipine is a calcium channel blocker used primarily for hypertension and angina. It does not have any antidepressant properties or similar therapeutic uses as trazodone. Therefore, there is no risk of therapeutic duplication when these drugs are prescribed together.

Conclusion

When evaluating potential drug interactions, it's crucial to identify medications that may overlap in therapeutic effects. Trazodone and nortriptyline both serve as antidepressants, making their concurrent use a concern for therapeutic duplication. In contrast, nabumetone, nystatin, and nicardipine do not share this concern due to their distinct therapeutic classes and uses.

Therapeutic duplication may be a concern for a patient prescribed both trazodone and:

Therapeutic duplication may be a concern for a patient prescribed both trazodone and nortriptyline.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test